News | Biopsy Systems | March 16, 2017

Exact Imaging Announces Health Canada Approval and License for ExactVu Micro-Ultrasound System

First Canadian customer will use prostate biopsy system in study to better understand apoptosis and how cancerous cells respond to therapy

Exact Imaging, Health Canada approval, ExactVu micro-ultrasound system, prostate biopsies, Sunnybrook Health Sciences Centre, Gregory Czarnota

March 16, 2017 — Exact Imaging has received Health Canada approval and the corresponding medical device license (#98667) to sell its ExactVu high resolution micro-ultrasound biopsy system in Canada. The first device was sold to Gregory Czarnota, M.D., and Sunnybrook Health Sciences Centre and Sunnybrook Research Institute in Toronto.

"The unmatched resolution of the ExactVu micro-ultrasound system will provide important capabilities to our urologists in helping them actually visualize and distinguish suspicious tissue — and therefore allows us to actually target our prostate biopsies," said Czarnota, director of the Odette Cancer Research Program, Sunnybrook Research Institute and Radiation Oncologist at Sunnybrook Health Sciences Centre. "Furthermore, the ExactVu's high resolution imaging also generates rich RF (or radiofrequency) data which our research teams can evaluate and correlate with pathology to apply against our models to better understand apoptosis and how cancerous cells respond to therapy. We see very exciting potential in the ExactVu system and look forward to our collaboration with the team at Exact Imaging."

Czarnota discovered that high-frequency ultrasound could be used to detect apoptosis or cell death. This finding has since been applied to important questions in oncology and organ transplantation. Czarnota's research group is investigating a number of spectroscopic parameters for characterizing tumors and tumor responses to chemotherapy and radiation therapy at high frequencies and intends to use the ExactVu for such purposes. Specific applications include developing methods to generate color-coded ultrasound parametric maps to aid in assessing tumor responses to therapy. Since these spectroscopic signals are potentially linked to nuclear structure and chromatin structure that differs between normal and neoplastic tissue, there is potential to develop our spectroscopic methods not only into a method to track tumor responses but a potentially important diagnostic tool.

For more information: www.exactimaging.com

Related Content

News | Ultrasound Imaging | May 15, 2017
Soundwaves LLC recently announced the diversification of its portable ultrasound services beyond obstetrics and...
FALCON Trial of Fluciclovine PET/CT Imaging Stops Recruitment after Successful Interim Analysis
News | Radiopharmaceuticals and Tracers | May 15, 2017
Blue Earth Diagnostics announced that the Trial Steering Committee recommended further recruitment be stopped in the...
radiologist reading ultrasound

Photo courtesy of Fujifilm

News | Clinical Study | May 11, 2017
According to new research by the Harvey L. Neiman Health Policy Institute, the use of follow-up imaging is...
Philips Introduces New OB/GYN Ultrasound Innovations for Epiq and Affiniti Systems
News | Ultrasound Womens Healthcare | May 10, 2017
Philips announced the debut of its TrueVue, GlassVue and aRevealA.I. capabilities on the company’s Epiq 7 and 5 and...
Strain Imaging Improves Cardiac Surveillance of Certain Breast Cancer Patients
News | Cardio-oncology | May 03, 2017
Epsilon Imaging Inc. announced a research study using EchoInsight was presented at the American College of Cardiology (...
Clarius Demonstrates Point-of-Care Ultrasound for Disaster and Emergency Medicine
News | Ultrasound Imaging | April 25, 2017
Clarius Mobile Health will demonstrate its wireless, handheld ultrasound scanners at the World Association for Disaster...
News | Prostate Cancer | April 24, 2017
April 24, 2017 — Cancer Targeted Technology recently announced it is focusing on small molecules that target pivotal
GE Healthcare and Echosens Introduce Integrated Liver Package for Logiq S8 XDclear 2.0 Ultrasound
News | Ultrasound Imaging | April 19, 2017
To further support clinicians in their fight against chronic liver disease, Echosens and GE Healthcare have joined...
Cardiovascular Institute of the South Upgrades Cardiac Ultrasound With New Toshiba Medical Systems
News | Cardiovascular Ultrasound | April 17, 2017
April 17, 2017 — To bolster its technology and treatment capabilities for coronary and peripheral artery diseases acr
MRI

Multiparametric MRI (MpMRI) has proved helpful in enhancing biopsy sampling for prostate cancer when combined with ultrasound. 

Feature | Prostate Cancer | April 10, 2017 | By Jeff Zagoudis
While prostate cancer is one of the most common cancers among American men — the third leading cause of cancer deaths...
Overlay Init